HXL — Hexima Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Hexima, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.69 | 2.02 | 3.68 | 6.01 | 0.695 |
| Change in Other Assets | |||||
| Cash from Operating Activities | -2.1 | -5.79 | -9.76 | -1.8 | -0.202 |
| Capital Expenditures | -0.002 | -0.002 | -0.003 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.003 | 0.002 | 0.002 | 0.039 | 0.138 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.001 | -0.001 | -0.002 | 0.039 | 0.138 |
| Financing Cash Flow Items | 0.064 | -0.797 | -0.699 | -0.004 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.46 | 7.9 | 10.3 | -0.004 | 0.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.593 | 2.06 | 0.535 | -1.77 | 0.037 |